Blog

Page 1 of 912345...Last »
Apr
20
2017

PFDD Sarcopenia Meeting Update

On April 6, the U.S. Food and Drug Administration (FDA) held its public meeting on Patient-Focused Drug Development (PFDD) for sarcopenia. The focus of the meeting was to obtain patient perspectives on “symptoms and the daily impacts of their condition, current approaches to treatment, and decision factors taken into account when... Read more »

Feb
2
2017

FDA Seeks Patient Perspectives on Sarcopenia

Do you or a loved one have sarcopenia? Or are you curious to understand more about how sarcopenia could impact you? The U.S. Food and Drug Administration wants to hear from you. On April 6, 2017, from 1 to 4 p.m. EST, the FDA will... Read more »

Dec
15
2016

AIM Coalition Hosts Second Annual Meeting

On December 1, the Aging in Motion (AIM) Coalition hosted its second annual meeting in Bethesda, Md., to discuss developments and advances in clinical research and treatment of sarcopenia. The meeting’s theme was “Advancing Therapeutic Development for Sarcopenia: Efforts to Improve Clinical Detection and Endpoint Measures,” which offered updates for stakeholders... Read more »

Aug
22
2016

AIM’s Bens Presents at August PDUFA VI Public Meeting

AIM Executive Director Cynthia Bens was invited by the U.S. Food and Drug Administration (FDA) to speak on two panels at an August 15 public meeting focused on the sixth reauthorization of the Prescription Drug User Fee Act (PDUFA). A few weeks ago, the FDA released its Read more »

Aug
9
2016

Q & A With Dr. Cyrus Cooper

Dr. Cyrus Cooper, who holds professorships at both the University of Southampton and the University of Oxford, is among the world's leading experts in sarcopenia research. We recently spoke with him about his work. Cooper2 Q: Could you tell us a little more... Read more »

Page 1 of 912345...Last »